The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily
about
Emerging Functions of RANKL in Lymphoid TissuesRecruitment of CD40 and tumor necrosis factor receptor-associated factors 2 and 3 to membrane microdomains during CD40 signalingTTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activationGene defect in ectodermal dysplasia implicates a death domain adapter in developmentReceptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6RANK is essential for osteoclast and lymph node developmentRANK-RANKL signalling in cancerRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsTRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosisSevere osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient miceTumor necrosis factor receptor-associated factors (TRAFs)Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling systemTRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingTRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungsOsteoclast differentiation is impaired in the absence of inhibitor of kappa B kinase alphaRANKL Is Necessary and Sufficient to Initiate Development of Antigen-Sampling M Cells in the Intestinal EpitheliumOsteoclast differentiation and activationMechanism of stimulation of osteoclastic bone resorption through Gas6/Tyro 3, a receptor tyrosine kinase signaling, in mouse osteoclasts.Mutations within the TNF-like core domain of RANKL impair osteoclast differentiation and activationBarley Seedling Extracts Inhibit RANKL-Induced Differentiation, Fusion, and Maturation of Osteoclasts in the Early-to-Late Stages of OsteoclastogenesisGene targeting in the analysis of mammalian apoptosis and TNF receptor superfamily signaling.Development of cell-based high-throughput assays for the identification of inhibitors of receptor activator of nuclear factor-kappa B signaling.Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.RANK receptor oligomerisation in the regulation of NFκB signalling.Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interactionSelective targeting of RANK signaling pathways as new therapeutic strategies for osteoporosis.Mechanisms balancing skeletal matrix synthesis and degradation.RANKL up-regulates brain-type creatine kinase via poly(ADP-ribose) polymerase-1 during osteoclastogenesis.Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.Biology of the RANKL-RANK-OPG System in Immunity, Bone, and Beyond.Regulatory mechanisms of osteoblast and osteoclast differentiation.Role of RANKL and RANK in bone loss and arthritis.Prospects for CD40-directed experimental therapy of human cancer.Receptor activator for nuclear factor-κB ligand signaling promotes progesterone-mediated estrogen-induced mammary carcinogenesis.Osteoclasts: New InsightsSignal peptide mutations in RANK prevent downstream activation of NF-κB.RANK (TNFRSF11A) is epigenetically inactivated and induces apoptosis in gliomas.The IVVY Motif and Tumor Necrosis Factor Receptor-associated Factor (TRAF) Sites in the Cytoplasmic Domain of the Receptor Activator of Nuclear Factor κB (RANK) Cooperate to Induce Osteoclastogenesis.Gene Expression Profile of Dendritic Cell-Tumor Cell Hybrids Determined by Microarrays and Its Implications for Cancer ImmunotherapyInhibition of Osteoclastogenesis and Bone Resorption in vitro and in vivo by a prenylflavonoid xanthohumol from hops
P2860
Q21131222-0307A62C-6134-4EC4-BDFC-CF49554EA93BQ22253441-E1A0251C-95F6-4041-B942-EC852EF34026Q22253885-3AB7F26D-A8C9-4A10-B162-A04C9ED9925CQ24292109-E78CC266-CD7F-4239-80A9-100F7AA4F61EQ24537518-DC6F3D00-2DD6-4F18-B559-9C31EA7B823AQ24598872-D31FB6E2-8B16-41A6-AEFB-3C12DFD1D509Q26747442-C95F6ADA-0FBE-4BE4-8B59-CF329EF80ED6Q26853280-A19BD94B-6157-4F0A-B149-C52FEB118A94Q28138885-A2AAA26B-9E75-4F49-B515-AB03F3210D8BQ28140546-1D9886AA-BA4C-4573-B012-1BDBA29C3D45Q28199382-B34B5BFD-0653-4DDD-A402-363B1471AC39Q28283972-ED2EC636-2A5A-446F-990A-A941CF3314CBQ28513445-E78045EB-7C27-4E4E-8D8E-9FD7AACDA767Q28587065-21B7F759-862B-4F0B-8722-5D54E16DE455Q28593804-C76C8A97-1CCF-4EF4-A5DC-A3157F377010Q29397534-05AE7914-AD3F-4FB1-842D-6490438762D8Q29547556-45DDF914-BD80-4983-9EAF-1A5DE3DE8B0BQ31577127-3DDE318A-FAC7-42CE-9352-65115370F3DCQ33642546-E18E3C0A-FAF0-42AC-98C2-1E4EFA1DB784Q33711211-73D0385A-B3DD-472E-8119-EB58D47E7C00Q33713375-49862237-A06B-454E-B630-B4F3110AECADQ33738074-B2C7EF74-2D36-4BC7-8F9D-75D0730DF515Q33782305-ED0CB760-98F0-490F-B5E6-E617DB1B368AQ33825207-713A5884-F0C5-468B-9361-D0E9869175D3Q33886695-C703A549-16F4-45A5-82FE-ABBED65C8C63Q34090842-BE8F8F6F-9A28-481E-B094-313F697BAAADQ34129759-80EB8AA5-7CD3-4BA9-97E4-1E373D647978Q34298974-85444308-EF37-4284-8270-F84FC8E26A21Q34333628-DCB76A26-82C4-4911-89FF-EA4019E4431FQ34366449-BAEA252E-9415-4A6C-9D2C-C2394F1BFCFCQ34728971-91BBA882-6191-409D-9F7B-92796495B6BAQ34963016-7F147881-AED6-4CBC-94B3-CEB59A168BACQ35028895-83E7FD44-17B6-4E07-90FA-4EDBF8EF3A9DQ35051324-1EA2F98D-DDA3-4B3D-85DA-80768AF78272Q35755039-35DF58FF-90F1-4181-869E-895F6FA4FD12Q36043987-929578BB-6A14-4841-BEB9-8C59D7365BB9Q36088188-23DE3654-7C51-4ECE-902A-2162CF78761FQ36093022-80498437-4292-4772-ABBD-344D894D5B81Q36269842-66E63A1D-ED7E-4FB9-A52A-1EA57E2D1A86Q36333546-A84B021F-DAF8-4755-8F59-29C75D4DEACE
P2860
The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily
description
1998 nî lūn-bûn
@nan
1998 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
name
The involvement of multiple tu ...... member of the TNFR superfamily
@ast
The involvement of multiple tu ...... member of the TNFR superfamily
@en
The involvement of multiple tu ...... member of the TNFR superfamily
@nl
type
label
The involvement of multiple tu ...... member of the TNFR superfamily
@ast
The involvement of multiple tu ...... member of the TNFR superfamily
@en
The involvement of multiple tu ...... member of the TNFR superfamily
@nl
prefLabel
The involvement of multiple tu ...... member of the TNFR superfamily
@ast
The involvement of multiple tu ...... member of the TNFR superfamily
@en
The involvement of multiple tu ...... member of the TNFR superfamily
@nl
P2093
P3181
P356
P1476
The involvement of multiple tu ...... member of the TNFR superfamily
@en
P2093
D M Anderson
L Galibert
M E Tometsko
W C Dougall
P304
P3181
P356
10.1074/JBC.273.51.34120
P407
P577
1998-12-18T00:00:00Z